Contact
Please use this form to send email to PR contact of this press release:
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
TO:
Please use this form to send email to PR contact of this press release:
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
TO: